Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)

Sanofi says it may look at next gen­er­a­tion of weight loss drugs: #JPM24

SAN FRAN­CIS­CO — Sanofi might not be done with the weight loss space af­ter all.

Af­ter its own GLP-1 drug failed a mid-stage tri­al al­most half …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.